Carl H. June, MD

Pathology University of Pennsylvania, Philadelphia, PA, United States 
"Carl June"


Sign in to add trainee
Luk H. Vandenberghe grad student Penn
Marcela V. Maus grad student 2003 Penn
Megan M. Suhoski grad student 2008 Penn
Tyler Reich research scientist 2014-2016 Penn (Chemistry Tree)


Sign in to add collaborator
Sadik H Kassim collaborator
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Diorio C, Shraim R, Myers R, et al. (2022) Comprehensive Serum Proteome Profiling of Cytokine Release Syndrome and Immune Effector Cell Associated Neurotoxicity Syndrome in B-Cell ALL Patients Receiving CART19. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Kalbasi A, Siurala M, Su LL, et al. (2022) Potentiating adoptive cell therapy using synthetic IL-9 receptors. Nature
Bai Z, Woodhouse S, Zhao Z, et al. (2022) Single-cell antigen-specific landscape of CAR T infusion product identifies determinants of CD19-positive relapse in patients with ALL. Science Advances. 8: eabj2820
Finck AV, Blanchard T, Roselle CP, et al. (2022) Engineered cellular immunotherapies in cancer and beyond. Nature Medicine. 28: 678-689
Young RM, Engel NW, Uslu U, et al. (2022) Next-Generation CAR T-cell Therapies. Cancer Discovery. OF1-OF14
Gill SI, Frey NV, Hexner E, et al. (2022) Anti-CD19 CAR T Cells in Combination with Ibrutinib for the Treatment of Chronic Lymphocytic Leukemia. Blood Advances
Narayan V, Barber-Rotenberg JS, Jung IY, et al. (2022) PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial. Nature Medicine
Feng Z, He X, Zhang X, et al. (2022) Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues. Nature Cancer
Smith M, Dai A, Ghilardi G, et al. (2022) Gut microbiome correlates of response and toxicity following anti-CD19 CAR T cell therapy. Nature Medicine
Giles JR, Manne S, Freilich E, et al. (2022) Human epigenetic and transcriptional T cell differentiation atlas for identifying functional T cell-specific enhancers. Immunity. 55: 557-574.e7
See more...